LOADING
Comparing JPMorgan Chase (JPM) and AbbVie Inc (ABBV) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JPM | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $949.8B | $465.0B |
| P/E Ratio | 15.3 | 126.5 |
| Forward P/E | 15.4 | 18.2 |
| PEG Ratio | 1.79 | 0.42 |
| EPS | $23.33 | $2.08 |
| Revenue Growth (YoY) | 30.4% | 12.4% |
| Profit Margin | 34.9% | 5.8% |
| Return on Equity | 17.8% | 62.3% |
| Dividend Yield | 1.68% | 2.62% |
| Beta | 0.98 | 0.28 |
| 52-Week High | $359.25 | $266.92 |
| 52-Week Low | $276.44 | $181.97 |
| Volume | -- | -- |
JPMorgan Chase is the larger company by market capitalization. JPMorgan Chase trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. JPMorgan Chase has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.